Managing Hypothyroidism in Pregnancy
For pregnant women with hypothyroidism, levothyroxine dosage should be increased by 12.5-25 mcg per day when TSH exceeds trimester-specific ranges, with monitoring every 4 weeks until TSH stabilizes within the normal trimester-specific range. 1
Initial Assessment and Monitoring
- Check TSH and free T4 as soon as pregnancy is confirmed and at minimum during each trimester 2, 1
- For women with pre-existing hypothyroidism:
Dosing Guidelines for Hypothyroidism in Pregnancy
Pre-existing Hypothyroidism:
- If TSH is above normal trimester-specific range:
Newly Diagnosed Hypothyroidism in Pregnancy:
- For TSH ≥10 IU/L: Start at 1.6 mcg/kg/day 1
- For TSH <10 IU/L: Start at 1.0 mcg/kg/day 1
- Monitor TSH every 4 weeks and adjust dosage until TSH is within trimester-specific range 1
Monitoring Schedule
- Check TSH and free T4 immediately upon pregnancy confirmation 4
- Monitor every 4 weeks throughout pregnancy 4
- More frequent monitoring (every 2-4 weeks) after dose adjustments 4
- Studies show that 43% of women have TSH values above recommended guidelines in the first trimester (>2.5 mU/L) 5
Risks of Inadequate Treatment
- Uncontrolled hypothyroidism during pregnancy is associated with:
- Increased risk of severe preeclampsia
- Preterm delivery
- Low birth weight
- Poor cognitive development in children 4
Risks of Overtreatment
- TSH <0.10 mIU/L during pregnancy increases the odds of preterm delivery (adjusted odds ratio: 2.14) 6
- Avoid overtreatment by careful monitoring and appropriate dose adjustments
Common Pitfalls and How to Avoid Them
Inadequate pre-conception optimization:
- Aim for TSH <1.2 mIU/L before conception to minimize the need for dose adjustments during pregnancy 3
Delayed monitoring:
- Studies show that 17.8% of women on thyroid replacement before conception do not have TSH measured during pregnancy 6
- Ensure prompt testing as soon as pregnancy is confirmed
Insufficient dose adjustments:
Failure to return to pre-pregnancy dose:
By following these guidelines and maintaining vigilant monitoring throughout pregnancy, the risks associated with both under-treatment and over-treatment of hypothyroidism can be minimized, leading to better maternal and fetal outcomes.